T2D & Insulin 2
Type 2 Diabetes Clinical Trial
Harold Hamm Diabetes Center is looking for volunteers to participate in a research study evaluating the safety and effectiveness of an investigational medication in people diagnosed with type 2 diabetes.
You might be eligible for this study if you:
- Are over 18 years of age
- Have been diagnosed with type 2 diabetes
- Are currently taking insulin detemir (Levemir) or insulin glargine (Lantus)
- Are currently taking a stable, daily dose of metformin
- Have an HbA1c level between 7.5 and 9.5 %
- Have a BMI of ≤ 40.0
Qualified participants will receive study-related medication, medical care, laboratory work, and glucose monitoring supplies at no cost.
To learn more about this study, please call (405) 271-3604.
The University of Oklahoma is an equal opportunity institution.